Epidemiology of Hepatitis B and Associated Liver Diseases in China
中国医学科学杂志(英文版)2012年第4期 页码:243-248
• REVIEW •|Updated:2024-04-10
|
Share with wechat friends or circle of friends
Export references
Epidemiology of Hepatitis B and Associated Liver Diseases in China
Affiliations:
1. Department of Infectious Diseases, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College,Beijing,China,100730
2. Office of Research Adminstration, Chinese Academy of Medical Sciences & Peking Union Medical College,Beijing,China,100730
3. ,China
4. Department of Medicine, Tufts University School of Medicine,Boston,USA,02111
Author bio:
Funds:
DOI:
中图分类号:
网络出版日期:2013-01-07,
纸质出版日期:2012
Accepted:
Scan QR Code
Yao Zhang, Hua Zhang, Au Elizabeth, 等. Epidemiology of Hepatitis B and Associated Liver Diseases in China[J]. 中国医学科学杂志(英文版), 2012,(4):243-248.
Yao Zhang, Hua Zhang, Au Elizabeth, et al. Epidemiology of Hepatitis B and Associated Liver Diseases in China[J]. Null, 2012, (4): 243-248.
Yao Zhang, Hua Zhang, Au Elizabeth, 等. Epidemiology of Hepatitis B and Associated Liver Diseases in China[J]. 中国医学科学杂志(英文版), 2012,(4):243-248.DOI:
Yao Zhang, Hua Zhang, Au Elizabeth, et al. Epidemiology of Hepatitis B and Associated Liver Diseases in China[J]. Null, 2012, (4): 243-248.DOI:
Epidemiology of Hepatitis B and Associated Liver Diseases in China
Hepatitis B virus (HBV) infection has long been a critical public health challenge in China. National surveys revealed a prevalence of approximate 10% for chronic HBV infection in general population. HBV has been the leading cause of chronic hepatitis
cirrhosis
and liver cancers in Chinese population and a common pathogen of acute viral hepatitis. Meanwhile
the epidemic provided important opportunities to research the natural history
public health impact
and therapeutic and preventive interventions for HBV in China. In this review
we summarized the selected key epidemiological studies since 1970s regarding HBV infection and its associated liver diseases in China
and provided considerations for future research
prevention and treatment of HBV.
Abstract
Abstract Hepatitis B virus (HBV) infection has long been a critical public health challenge in China. National surveys revealed a prevalence of approximate 10% for chronic HBV infection in general population. HBV has been the leading cause of chronic hepatitis
cirrhosis
and liver cancers in Chinese population and a common pathogen of acute viral hepatitis. Meanwhile
the epidemic provided important opportunities to research the natural history
public health impact
and therapeutic and preventive interventions for HBV in China. In this review
we summarized the selected key epidemiological studies since 1970s regarding HBV infection and its associated liver diseases in China
STUDY ON SMALL HEPATOCELLULAR CARCINOMAAND ITS EXTENSION
NATIONAL SURVEY ON PREVALENCE OF CANCER PAIN
TRENDS OF CASE DETECTION AND OTHER INDICATORS OF LEPROSY IN CHINA DURING 1985-2002
IN VIVO 1 H MAGNETIC RESONANCE SPECTROSCOPY IN EVALUATION OF HEPATOCELLULAR CARCINOMA AND ITS EARLY RESPONSE TO TRANSCATHETER ARTERIAL CHEMOEMBOLIZATION
Application of Positron Emission Tomography Molecular Probes in Hepatocellular Carcinoma Biological Imaging
相关作者
and Jia-he Tian
Ting-ting He
and Bao-cai Xing
Ke-min Jin
Li Zhou
Ye Jin
Jing-hua Zhang
Gang Xu
相关机构
Chetpet
India Council of Medical Research
National Institute of Epidemiology
Department of Nuclear Medicine, General Hospital of the Chinese People’s Liberation Army
Department of General Surgery, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College